Clinical Trial Update: BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.

View source ↗

Summary

An international experience update evaluating the Evolut platform for transcatheter aortic valve replacement in patients with bicuspid aortic stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis
• Bicuspid Aortic Valve Disease

Drugs mentioned

• Evolut Platform

Snippet

Sponsor: Clinique Pasteur | Conditions: Bicuspid Aortic Valve | Status: UNKNOWN